Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Prognostic Nomogram of Extranodal NK/T-cell Lymphoma: A Multi-center Retrospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04554511

Enrollment

1000

Registered

2020-09-18

Start date

2020-08-28

Completion date

2024-01-01

Last updated

2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extranodal NK/T-cell Lymphoma

Brief summary

This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.

Detailed description

This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients newly diagnosed with ENKTL * Patients diagnosed between January 1, 2000 and August 31, 2020 * Patients older than 18 years

Exclusion criteria

* Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.

Design outcomes

Primary

Measure	Time frame	Description
Overall survival	5 year	Time between the date of diagnosis and any kinds of death

Secondary

Measure	Time frame	Description
Progression-free survival	5 year	Time between the date of diagnosis and any kinds of death or relapse/progression

Countries

China

Contacts

Primary ContactHua Wang

wanghua@sysucc.org.cn+862087342462

Outcome results